本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ginkgo Bioworks Holdings Inc.

7.67
-0.1600-2.04%
盘前7.690.0200+0.26%04:37 EDT
成交量:61.81万
成交额:470.87万
市值:4.49亿
市盈率:-0.73
高:7.76
开:7.73
低:7.41
收:7.83
数据加载中...
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/01/27

重要事件披露

8-K - Current report
2023/01/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/01/11

重要事件披露

8-K - Current report
2022/11/18

重要事件披露

8-K - Current report
2022/11/14

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/19

重要事件披露

8-K - Current report
2022/10/19

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/10/12

SEC问询函

CORRESP [Cover] - Correspondence
2022/10/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/10/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/05

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/04

重要事件披露

8-K - Current report
2022/09/27

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/27

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933